U.S. federal trademark · Serial No. 99245347
Pharmaceutical preparation, namely, a recombinant, human monoclonal antibody antigen-binding fragment designed to reverse the antiplatelet activity of ticagrelor in major bleeding and urgent surgery situations
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.